» Articles » PMID: 20596760

Heparinized Hydroxyapatite/collagen Three-dimensional Scaffolds for Tissue Engineering

Overview
Publisher Springer
Date 2010 Jul 3
PMID 20596760
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Currently, in bone tissue engineering research, the development of appropriate biomaterials for the regeneration of bony tissues is a major concern. Bone tissue is composed of a structural protein, collagen type I, on which calcium phosphate crystals are enclosed. For tissue engineering, one of the most applied strategies consists on the development and application of three dimensional porous scaffolds with similar composition to the bone. In this way, they can provide a physical support for cell attachment, proliferation, nutrient transport and new bone tissue infiltration. Hydroxyapatite is a calcium phosphate with a similar composition of bone and widely applied in several medical/dentistry fields. Therefore, in this study, hydroxyapatite three dimensional porous scaffolds were produced using the polymer replication method. Next, the porous scaffolds were homogeneously coated with a film of collagen type I by applying vacuum force. Yet, due to collagen degradability properties, it was necessary to perform an adequate crosslinking method. As a result, N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) was employed as an efficient and non-toxic crosslinking method in this research. The composites were characterized by means of SEM, DSC and TNBS. Furthermore, heparin was incorporated in order to accomplish sustained delivery of a growth factor of interest namely, bone morphogenetic proteins (BMP-2). BMP-2 binding and release of non-heparinized and heparinized scaffolds was evaluated at specific time points. The incorporation of heparin leads to a reduced initial burst phase when compared to the non heparinized materials. The results show a beneficial effect with the incorporation of heparin and its potential as a localized drug delivery system for the sustained release of growth factors.

Citing Articles

Polysaccharide-Based Composite Systems in Bone Tissue Engineering: A Review.

Niziolek K, Slota D, Sobczak-Kupiec A Materials (Basel). 2024; 17(17).

PMID: 39274610 PMC: 11396420. DOI: 10.3390/ma17174220.


An Overview on the Big Players in Bone Tissue Engineering: Biomaterials, Scaffolds and Cells.

Ferraz M Int J Mol Sci. 2024; 25(7).

PMID: 38612646 PMC: 11012232. DOI: 10.3390/ijms25073836.


Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model.

Alegrete N, Sousa S, Padrao T, Carvalho A, Lucas R, Canadas R Bioengineering (Basel). 2023; 10(2).

PMID: 36829700 PMC: 9952702. DOI: 10.3390/bioengineering10020206.


Delivery of bone morphogenetic protein-2 by crosslinking heparin to nile tilapia skin collagen for promotion of rat calvaria bone defect repair.

Ma L, Fu L, Gu C, Wang H, Yu Z, Gao X Prog Biomater. 2022; 12(1):61-73.

PMID: 36495399 PMC: 9958213. DOI: 10.1007/s40204-022-00213-7.


Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2.

Hettiaratchi M, Miller T, Temenoff J, Guldberg R, McDevitt T Biomaterials. 2014; 35(25):7228-38.

PMID: 24881028 PMC: 4093826. DOI: 10.1016/j.biomaterials.2014.05.011.


References
1.
Edlund U, Danmark S, Albertsson A . A strategy for the covalent functionalization of resorbable polymers with heparin and osteoinductive growth factor. Biomacromolecules. 2008; 9(3):901-5. DOI: 10.1021/bm701267u. View

2.
Kong L, Gao Y, Cao W, Gong Y, Zhao N, Zhang X . Preparation and characterization of nano-hydroxyapatite/chitosan composite scaffolds. J Biomed Mater Res A. 2005; 75(2):275-82. DOI: 10.1002/jbm.a.30414. View

3.
Maeda H, Kasuga T, Hench L . Preparation of poly(L-lactic acid)-polysiloxane-calcium carbonate hybrid membranes for guided bone regeneration. Biomaterials. 2005; 27(8):1216-22. DOI: 10.1016/j.biomaterials.2005.08.010. View

4.
Steffens G, Yao C, Prevel P, Markowicz M, Schenck P, Noah E . Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng. 2004; 10(9-10):1502-9. DOI: 10.1089/ten.2004.10.1502. View

5.
Yamamoto M, Tabata Y, Hong L, Miyamoto S, Hashimoto N, Ikada Y . Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. J Control Release. 2000; 64(1-3):133-42. DOI: 10.1016/s0168-3659(99)00129-7. View